Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1757)
All Articles published online
|
Mar 21, 2008 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tischoff I, Tannapfel A. DNA methylation in hepatocellular carcinoma. World J Gastroenterol 2008; 14(11): 1741-1748 [PMID: 18350605 DOI: 10.3748/wjg.14.1741] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v14/i11/1741.htm |
| Number | Citing Articles |
| 1 |
Eric J. Formeister, Masato Tsuchiya, Hideki Fujii, Svitlana Shpyleva, Igor P. Pogribny, Ivan Rusyn. Comparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinoma. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2010; 692(1-2): 26 doi: 10.1016/j.mrfmmm.2010.07.013
|
| 2 |
Mohamed A. Mekky, Rgaa H. Salama, Mahmoud F. Abdel-Aal, Mohamed A. Ghaliony, Saad Zaky. Studying the frequency of aberrant DNA methylation of APC, P14, and E-cadherin genes in HCV-related hepatocarcinogenesis. Cancer Biomarkers 2018; 22(3): 503 doi: 10.3233/CBM-171156
|
| 3 |
Chunxia Zhu, Xuefeng Feng, Guoliang Ye, Tao Huang. Meta-analysis of possible role of cadherin gene methylation in evolution and prognosis of hepatocellular carcinoma with a PRISMA guideline. Medicine 2017; 96(16): e6650 doi: 10.1097/MD.0000000000006650
|
| 4 |
Hongyan Liu, Huijia Dong, Keith Robertson, Chen Liu. DNA Methylation Suppresses Expression of the Urea Cycle Enzyme Carbamoyl Phosphate Synthetase 1 (CPS1) in Human Hepatocellular Carcinoma. The American Journal of Pathology 2011; 178(2): 652 doi: 10.1016/j.ajpath.2010.10.023
|
| 5 |
Patrick Kwok Shing Ng, Carol Po Ying Lau, Emily Kai Yee Lam, Sheila Sai Kam Li, Vivian Wai Yan Lui, Winnie Yeo, Yuen Keng Ng, Paul Bo San Lai, Stephen Kwok Wing Tsui. Hypermethylation of NF-κB-Activating Protein-Like (NKAPL) Promoter in Hepatocellular Carcinoma Suppresses Its Expression and Predicts a Poor Prognosis. Digestive Diseases and Sciences 2018; 63(3): 676 doi: 10.1007/s10620-018-4929-3
|
| 6 |
Azhwar Raghunath, Kiruthika Sundarraj, Frank Arfuso, Gautam Sethi, Ekambaram Perumal. Dysregulation of Nrf2 in Hepatocellular Carcinoma: Role in Cancer Progression and Chemoresistance. Cancers 2018; 10(12): 481 doi: 10.3390/cancers10120481
|
| 7 |
Bei Zhang, Siqi Han, Bing Feng, Xiaoyuan Chu, Longbang Chen, Rui Wang. Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma. Experimental & Molecular Medicine 2017; 49(2): e293 doi: 10.1038/emm.2016.177
|
| 8 |
Xueyan Dong, Qiang Hou, Yueming Chen, Xianjun Wang. Diagnostic Value of the Methylation of Multiple Gene Promoters in Serum in Hepatitis B Virus-Related Hepatocellular Carcinoma. Disease Markers 2017; 2017: 1 doi: 10.1155/2017/2929381
|
| 9 |
Rui-kun Zhang, Jia-lin Liu. Screening the genome for HCC-specific CpG methylation signatures as biomarkers for diagnosis and prognosis evaluation. BMC Medical Genomics 2021; 14(1) doi: 10.1186/s12920-021-01015-9
|
| 10 |
Dandan Niu, Jianhua Zhang, Yudan Ren, Huixing Feng, Wei Ning Chen. HBx genotype D represses GSTP1 expression and increases the oxidative level and apoptosis in HepG2 cells. Molecular Oncology 2009; 3(1): 67 doi: 10.1016/j.molonc.2008.10.002
|
| 11 |
Xin Wang, Ya Cheng, Liang-liang Yan, Ran An, Xing-yu Wang, Heng-yi Wang. <p>Exploring DNA Methylation Profiles Altered in Cryptogenic Hepatocellular Carcinomas by High-Throughput Targeted DNA Methylation Sequencing: A Preliminary Study for Cryptogenic Hepatocellular Carcinoma</p>. OncoTargets and Therapy 2020; : 9901 doi: 10.2147/OTT.S267812
|
| 12 |
Jingjing Yu, Brittany G. Sullivan, Girish N. Senthil, Amber Gonda, Farideh Dehkordi-Vakil, Belinda Campos, Farshid Dayyani, Maheswari Senthil. Prevalence of Primary Liver Cancer is Affected by Place of Birth in Hispanic People Residing in the United States: All of Us Research Program Report. The American Surgeon 2022; 88(10): 2565 doi: 10.1177/00031348221109465
|
| 13 |
Ole Ammerpohl, Johann Pratschke, Clemens Schafmayer, Andrea Haake, Wladimir Faber, Oliver von Kampen, Mario Brosch, Bence Sipos, Witigo von Schönfels, Katharina Balschun, Christoph Röcken, Alexander Arlt, Bodo Schniewind, Jonas Grauholm, Holger Kalthoff, Peter Neuhaus, Felix Stickel, Stefan Schreiber, Thomas Becker, Reiner Siebert, Jochen Hampe. Distinct DNA methylation patterns in cirrhotic liver and hepatocellular carcinoma. International Journal of Cancer 2012; 130(6): 1319 doi: 10.1002/ijc.26136
|
| 14 |
MITSURO KANDA, SHUJI NOMOTO, HISAHARU OYA, HIDEKI TAKAMI, SOKI HIBINO, MITSUHIRO HISHIDA, MASAYA SUENAGA, SUGURU YAMADA, YOSHIKUNI INOKAWA, YOKO NISHIKAWA, MIKAKO ASAI, TSUTOMU FUJII, HIROYUKI SUGIMOTO, YASUHIRO KODERA. Downregulation of DENND2D by promoter hypermethylation is associated with early recurrence of hepatocellular carcinoma. International Journal of Oncology 2014; 44(1): 44 doi: 10.3892/ijo.2013.2165
|
| 15 |
Grażyna Kostka, Katarzyna Urbanek‐Olejnik, Monika Liszewska, Alicja Winczura. The effect of acute dichlorodiphenyltrichloroethane exposure on hypermethylation status and down‐regulation of p53 and p16INK4a genes in rat liver. Environmental Toxicology 2016; 31(5): 584 doi: 10.1002/tox.22071
|
| 16 |
Jing Shen, Shuang Wang, Yu-Jing Zhang, Hui-Chen Wu, Muhammad G. Kibriya, Farzana Jasmine, Habibul Ahsan, David PH Wu, Abby B. Siegel, Helen Remotti, Regina M. Santella. Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics 2013; 8(1): 34 doi: 10.4161/epi.23062
|
| 17 |
Yangxing Zhao, Feng Xue, Jinfeng Sun, Shicheng Guo, Hongyu Zhang, Bijun Qiu, Junfeng Geng, Jun Gu, Xiaoyu Zhou, Wei Wang, Zhenfeng Zhang, Ning Tang, Yinghua He, Jian Yu, Qiang Xia. Genome-wide methylation profiling of the different stages of hepatitis B virus-related hepatocellular carcinoma development in plasma cell-free DNA reveals potential biomarkers for early detection and high-risk monitoring of hepatocellular carcinoma. Clinical Epigenetics 2014; 6(1) doi: 10.1186/1868-7083-6-30
|
| 18 |
Yu-Jia Gao, Yan Xin, Jian-Jun Zhang, Jin Zhou. Mechanism and pathobiologic implications of CHFR promoter methylation in gastric carcinoma. World Journal of Gastroenterology 2008; 14(32): 5000-5007 doi: 10.3748/wjg.14.5000
|
| 19 |
Zi-Lun Lai, Yung-An Tsou, Shin-Ru Fan, Ming-Hsui Tsai, Hsiao-Ling Chen, Nai-Wen Chang, Ju-Chien Cheng, Chuan-Mu Chen. Methylation-Associated Gene Silencing ofRARBin Areca Carcinogens Induced Mouse Oral Squamous Cell Carcinoma. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/378358
|
| 20 |
M-H Lee, H Na, T-Y Na, Y-K Shin, J-K Seong, M-O Lee. Epigenetic control of metastasis-associated protein 1 gene expression by hepatitis B virus X protein during hepatocarcinogenesis. Oncogenesis 2012; 1(9): e25 doi: 10.1038/oncsis.2012.26
|
| 21 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_169-1
|
| 22 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3043 doi: 10.1007/978-3-319-26956-6_169
|
| 23 |
Alejandra Ward, Alan Morettin, David Shum, John W Hudson. Aberrant methylation of Polo-like kinase CpG islands in Plk4 heterozygous mice. BMC Cancer 2011; 11(1) doi: 10.1186/1471-2407-11-71
|
| 24 |
Xiaowen Huang, Chen Yang, Jilin Wang, Tiantian Sun, Hua Xiong. Integrative analysis of DNA methylation and gene expression reveals distinct hepatocellular carcinoma subtypes with therapeutic implications. Aging 2020; 12(6): 4970 doi: 10.18632/aging.102923
|
| 25 |
W Liu, J Wang, L Wang, C Qian, Y Qian, H Xuan, W Zhuo, X Li, J Yu, J Si. Ras-association domain family 10 acts as a novel tumor suppressor through modulating MMP2 in hepatocarcinoma. Oncogenesis 2016; 5(6): e237 doi: 10.1038/oncsis.2016.24
|
| 26 |
Shu-Huei Hsiao, Tim H.-M. Huang, Yu-Wei Leu. Excavating relics of DNA methylation changes during the development of neoplasia. Seminars in Cancer Biology 2009; 19(3): 198 doi: 10.1016/j.semcancer.2009.02.015
|
| 27 |
Maria Maryam, Muhammad Idrees. Study of promoter hypomethylation profiles of RAS oncogenes in hepatocellular carcinoma derived from hepatitis C virus genotype 3a in Pakistani population. Journal of Medical Virology 2018; 90(9): 1516 doi: 10.1002/jmv.25221
|
| 28 |
Quanyan Liu, Li Liu, Yuhong Zhao, Jin Zhang, Dongfeng Wang, Jiwei Chen, Yueming He, Jianguo Wu, Zhonglin Zhang, Zhisu Liu. Hypoxia Induces Genomic DNA Demethylation through the Activation of HIF-1α and Transcriptional Upregulation of MAT2A in Hepatoma Cells. Molecular Cancer Therapeutics 2011; 10(6): 1113 doi: 10.1158/1535-7163.MCT-10-1010
|
| 29 |
Mudassier Ahmad, Anupam Dhasmana, Prateek Suresh Harne, Asif Zamir, Bilal Bin Hafeez. Chemokine clouding and liver cancer heterogeneity: Does it impact clinical outcomes?. Seminars in Cancer Biology 2022; 86: 1175 doi: 10.1016/j.semcancer.2022.02.015
|
| 30 |
Yuan Yang, Linghao Zhao, Bo Huang, Guojun Hou, Beibei Zhou, Jin Qian, Shengxian Yuan, Huasheng Xiao, Minghui Li, Weiping Zhou. A New Approach to Evaluating Aberrant DNA Methylation Profiles in Hepatocellular Carcinoma as Potential Biomarkers. Scientific Reports 2017; 7(1) doi: 10.1038/srep46533
|
| 31 |
Qing-Lian Chen, Qian Yan, Kun-Liang Feng, Chun-Feng Xie, Chong-Kai Fang, Ji-Nan Wang, Li-Hua Liu, Ya Li, Chong Zhong. Using Integrated Bioinformatics Analysis to Identify Abnormally Methylated Differentially Expressed Genes in Hepatocellular Carcinoma. International Journal of General Medicine 2021; : 805 doi: 10.2147/IJGM.S294505
|
| 32 |
|
| 33 |
Yi Tian, Dongjing Ni, Weibing Yang, Yi Zhang, Keji Zhao, Jianxun Song, Qing Mao, Zhiqiang Tian, Jennifer C. van Velkinburgh, Di Yang, Yuzhang Wu, Bing Ni. Telbivudine treatment corrects HBV-induced epigenetic alterations in liver cells of patients with chronic hepatitis B. Carcinogenesis 2014; 35(1): 53 doi: 10.1093/carcin/bgt317
|
| 34 |
Xiaoli Liao, Junming Chen, DongCheng Luo, Baohua Luo, Wenfeng Huang, Weimin Xie. Prognostic value of long non-coding RNA MALAT1 in hepatocellular carcinoma: A study based on multi-omics analysis and RT-PCR validation. Pathology and Oncology Research 2023; 28 doi: 10.3389/pore.2022.1610808
|
| 35 |
Siyu Fu, José D. Debes, André Boonstra. DNA methylation markers in the detection of hepatocellular carcinoma. European Journal of Cancer 2023; 191: 112960 doi: 10.1016/j.ejca.2023.112960
|
| 36 |
Yuan-Yuan Zhang, Harry Hua-Xiang Xia. Novel therapeutic approaches for hepatocellulcar carcinoma: Fact and fiction. World Journal of Gastroenterology 2008; 14(11): 1641-1642 doi: 10.3748/wjg.14.1641
|
| 37 |
Hyehyeon Lee, Young-Ju Woo, Soo Shin Kim, Sung-Hyun Kim, Bum-Joon Park, Dongho Choi, Kyung Lib Jang. Hepatitis C virus Core protein overcomes all-trans retinoic acid-induced cell growth arrest by inhibiting retinoic acid receptor-β2 expression via DNA methylation. Cancer Letters 2013; 335(2): 372 doi: 10.1016/j.canlet.2013.02.057
|
| 38 |
Kazuaki Kawai, Yun-Shan Li, Ming-Fen Song, Yuko Ootsuyama, Anna Kakehashi, Hideki Wanibuchi, Akira Ootsuyama, Toshiyuki Norimura, Hiroshi Kasai. Methionine Sulfoxide Stimulates Hepatocarcinogenesis in Non-alcoholic Steatohepatitis (NASH) Mouse: Possible Role of Free Radical-mediated DNA Methylation. Genes and Environment 2012; 34(3): 123 doi: 10.3123/jemsge.34.123
|
| 39 |
Raksha Mudbhary, Yujin Hoshida, Yelena Chernyavskaya, Vinitha Jacob, Augusto Villanueva, M. Isabel Fiel, Xintong Chen, Kensuke Kojima, Swan Thung, Roderick T. Bronson, Anja Lachenmayer, Kate Revill, Clara Alsinet, Ravi Sachidanandam, Anal Desai, Sucharita SenBanerjee, Chinweike Ukomadu, Josep M. Llovet, Kirsten C. Sadler. UHRF1 Overexpression Drives DNA Hypomethylation and Hepatocellular Carcinoma. Cancer Cell 2014; 25(2): 196 doi: 10.1016/j.ccr.2014.01.003
|
| 40 |
Ioannis Anestopoulos, Georgia Persephoni Voulgaridou, Alexandros G. Georgakilas, Rodrigo Franco, Aglaia Pappa, Mihalis I. Panayiotidis. Epigenetic therapy as a novel approach in hepatocellular carcinoma. Pharmacology & Therapeutics 2015; 145: 103 doi: 10.1016/j.pharmthera.2014.09.005
|
| 41 |
Qiaojiajie Zhao, Weihua Cai, Xuan Zhang, Shuo Tian, Junwen Zhang, Haibo Li, Congcong Hou, Xiaoli Ma, Hong Chen, Bingren Huang, Deng Chen. RYBP Expression Is Regulated by KLF4 and Sp1 and Is Related to Hepatocellular Carcinoma Prognosis. Journal of Biological Chemistry 2017; 292(6): 2143 doi: 10.1074/jbc.M116.770727
|
| 42 |
Khadija Rebbani, Agnès Marchio, Sayeh Ezzikouri, Rajaa Afifi, Mostafa Kandil, Olfa Bahri, Henda Triki, Abdellah Essaid El Feydi, Anne Dejean, Soumaya Benjelloun, Pascal Pineau. TP53 R72P polymorphism modulates DNA methylation in hepatocellular carcinoma. Molecular Cancer 2015; 14(1) doi: 10.1186/s12943-015-0340-2
|
| 43 |
Jing-zhe Sun, Xue-xi Yang, Xiang-hong Li, Wei-wen Xu, Ying Wang, Wei Zhu, Ming Li. Aberrant CpG Island Hypermethylation and Down-Regulation of Oct-6 mRNA Expression in Human Hepatocellular Carcinoma. Digestive Diseases and Sciences 2011; 56(10): 3072 doi: 10.1007/s10620-011-1686-y
|
| 44 |
CHENG-RONG XIE, HONGGUANG SUN, FU-QIANG WANG, ZHAO LI, YI-RUI YIN, QIN-LIANG FANG, YU SUN, WEN-XIU ZHAO, SHENG ZHANG, WEN-XING ZHAO, XIAO-MIN WANG, ZHEN-YU YIN. Integrated analysis of gene expression and DNA methylation changes induced by hepatocyte growth factor in human hepatocytes. Molecular Medicine Reports 2015; 12(3): 4250 doi: 10.3892/mmr.2015.3974
|
| 45 |
Ying‐Bing Deng, Genta Nagae, Yutaka Midorikawa, Koichi Yagi, Shuichi Tsutsumi, Shogo Yamamoto, Kiyoshi Hasegawa, Norihiro Kokudo, Hiroyuki Aburatani, Atsushi Kaneda. Identification of genes preferentially methylated in hepatitis C virus‐related hepatocellular carcinoma. Cancer Science 2010; 101(6): 1501 doi: 10.1111/j.1349-7006.2010.01549.x
|
| 46 |
Yoshikuni Inokawa, Kenichi Inaoka, Fuminori Sonohara, Masamichi Hayashi, Mitsuro Kanda, Shuji Nomoto. Molecular alterations in the carcinogenesis and progression of hepatocellular carcinoma: Tumor factors and background liver factors. Oncology Letters 2016; 12(5): 3662 doi: 10.3892/ol.2016.5141
|
| 47 |
Mark J. Hoenerhoff, Arun R. Pandiri, Stephanie A. Lahousse, Hu-Hua Hong, Tai-Vu Ton, Tiwanda Masinde, Scott S. Auerbach, Kevin Gerrish, Pierre R. Bushel, Keith R. Shockley, Shyamal D. Peddada, Robert C. Sills. Global Gene Profiling of Spontaneous Hepatocellular Carcinoma in B6C3F1 Mice. Toxicologic Pathology 2011; 39(4): 678 doi: 10.1177/0192623311407213
|
| 48 |
GUOXUN FENG, YAN ZHANG, HUISHENG YUAN, RIXING BAI, JIANWEI ZHENG, JINQIAN ZHANG, MAOMIN SONG. DNA methylation of trefoil factor 1 (TFF1) is associated with the tumorigenesis of gastric carcinoma. Molecular Medicine Reports 2014; 9(1): 109 doi: 10.3892/mmr.2013.1772
|
| 49 |
Yang Li, Yihong Cai, He Chen, Leijin Mao. Clinical significance and association of GSTP1 hypermethylation with hepatocellular carcinoma. Journal of Cancer Research and Therapeutics 2018; 14(Suppl 2): S486 doi: 10.4103/0973-1482.181179
|
| 50 |
Yoko Komatsu, Tsuyoshi Waku, Naoya Iwasaki, Wakana Ono, Chie Yamaguchi, Junn Yanagisawa. Global analysis of DNA methylation in early-stage liver fibrosis. BMC Medical Genomics 2012; 5(1) doi: 10.1186/1755-8794-5-5
|
| 51 |
Ewa Wolinska, Maciej Skrzypczak. Epigenetic Changes Affecting the Development of Hepatocellular Carcinoma. Cancers 2021; 13(16): 4237 doi: 10.3390/cancers13164237
|
| 52 |
Divya Mishra, Ashish Mishra, Sachchida Nand Rai, Emanuel Vamanu, Mohan P. Singh. Identification of Prognostic Biomarkers for Suppressing Tumorigenesis and Metastasis of Hepatocellular Carcinoma through Transcriptome Analysis. Diagnostics 2023; 13(5): 965 doi: 10.3390/diagnostics13050965
|
| 53 |
Peifeng Ruan, Jing Shen, Regina M. Santella, Shuigeng Zhou, Shuang Wang. NEpiC: a network-assisted algorithm for epigenetic studies using mean and variance combined signals. Nucleic Acids Research 2016; 44(16): e134 doi: 10.1093/nar/gkw546
|
| 54 |
Fei Gao, Huifang Liang, Hanlin Lu, Junwen Wang, Meng Xia, Zhimei Yuan, Yu Yao, Tong Wang, Xiaolong Tan, Arian Laurence, Hua Xu, Jingjing Yu, Wei Xiao, Wei Chen, Ming Zhou, Xiuqing Zhang, Qian Chen, Xiaoping Chen. Global analysis of DNA methylation in hepatocellular carcinoma by a liquid hybridization capture-based bisulfite sequencing approach. Clinical Epigenetics 2015; 7(1) doi: 10.1186/s13148-015-0121-1
|
| 55 |
Thomas Tu, Magdalena Budzinska, Annette Maczurek, Robert Cheng, Anna Di Bartolomeo, Fiona Warner, Geoffrey McCaughan, Susan McLennan, Nicholas Shackel. Novel Aspects of the Liver Microenvironment in Hepatocellular Carcinoma Pathogenesis and Development. International Journal of Molecular Sciences 2014; 15(6): 9422 doi: 10.3390/ijms15069422
|
| 56 |
Chiara Raggi, Pietro Invernizzi. Methylation and liver cancer. Clinics and Research in Hepatology and Gastroenterology 2013; 37(6): 564 doi: 10.1016/j.clinre.2013.05.009
|
| 57 |
Nuno Paula Santos, Aura Antunes Colaço, Paula Alexandra Oliveira. Animal models as a tool in hepatocellular carcinoma research: A Review. Tumor Biology 2017; 39(3): 101042831769592 doi: 10.1177/1010428317695923
|
| 58 |
Nithar Ranjan Madhu, Bhanumati Sarkar, Shubhadeep Roychoudhury, Biplab Kumar Behera. Handbook of Animal Models and its Uses in Cancer Research. 2023; : 545 doi: 10.1007/978-981-19-3824-5_61
|
| 59 |
Qiuzi Dai, Cunlong Zhang, Zigao Yuan, Qinsheng Sun, Yuyang Jiang. Current discovery strategies for hepatocellular carcinoma therapeutics. Expert Opinion on Drug Discovery 2020; 15(2): 243 doi: 10.1080/17460441.2020.1696769
|
| 60 |
Zdenko Herceg, Anupam Paliwal. HBV protein as a double-barrel shot-gun targets epigenetic landscape in liver cancer. Journal of Hepatology 2009; 50(2): 252 doi: 10.1016/j.jhep.2008.11.013
|
| 61 |
Satoshi Matsumura, Issei Imoto, Ken-ichi Kozaki, Takeshi Matsui, Tomoki Muramatsu, Mayuko Furuta, Shinji Tanaka, Michiie Sakamoto, Shigeki Arii, Johji Inazawa. Integrative Array-Based Approach Identifies MZB1 as a Frequently Methylated Putative Tumor Suppressor in Hepatocellular Carcinoma. Clinical Cancer Research 2012; 18(13): 3541 doi: 10.1158/1078-0432.CCR-11-1007
|
| 62 |
Shelby L. Buckner, Allison N. Pruitt, Cecilia N. Thomas, Monisha Y. Amin, Laurence L. Miller, Faith E. Wiley, Maria Eugenia Sabbatini. Di-N-octylphthalate acts as a proliferative agent in murine cell hepatocytes by regulating the levels of TGF-β and pro-apoptotic proteins. Food and Chemical Toxicology 2018; 111: 166 doi: 10.1016/j.fct.2017.11.005
|
| 63 |
James P Hamilton. Epigenetic mechanisms involved in the pathogenesis of hepatobiliary malignancies. Epigenomics 2010; 2(2): 233 doi: 10.2217/epi.10.9
|
| 64 |
Ryan A. Hlady, Rochelle L. Tiedemann, William Puszyk, Ivan Zendejas, Lewis R. Roberts, Jeong-Hyeon Choi, Chen Liu, Keith D. Robertson. Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis. Oncotarget 2014; 5(19): 9425 doi: 10.18632/oncotarget.2444
|
| 65 |
Jing Shen, Shuang Wang, Yu-Jing Zhang, Maya Kappil, Hui-Chen Wu, Muhammad G. Kibriya, Qiao Wang, Farzana Jasmine, Habib Ahsan, Po-Huang Lee, Ming-Whei Yu, Chien-Jen Chen, Regina M. Santella. Genome-wide DNA methylation profiles in hepatocellular carcinoma. Hepatology 2012; 55(6): 1799 doi: 10.1002/hep.25569
|
| 66 |
Igor P. Pogribny, Ivan Rusyn. Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma. Cancer Letters 2014; 342(2): 223 doi: 10.1016/j.canlet.2012.01.038
|
| 67 |
Raksha Mudbhary, Kirsten C. Sadler. Epigenetics, development, and cancer: Zebrafish make their mark. Birth Defects Research Part C: Embryo Today: Reviews 2011; 93(2): 194 doi: 10.1002/bdrc.20207
|
| 68 |
Min-Ae Song, Maarit Tiirikainen, Sandi Kwee, Gordon Okimoto, Herbert Yu, Linda L. Wong, Alejandro H. Corvalan. Elucidating the Landscape of Aberrant DNA Methylation in Hepatocellular Carcinoma. PLoS ONE 2013; 8(2): e55761 doi: 10.1371/journal.pone.0055761
|
| 69 |
Anna Potapova, Cord Albat, Britta Hasemeier, Katrin Haeussler, Stella Lamprecht, Sebastian Suerbaum, Hans Kreipe, Ulrich Lehmann. Systematic cross-validation of 454 sequencing and pyrosequencing for the exact quantification of DNA methylation patterns with single CpG resolution. BMC Biotechnology 2011; 11(1) doi: 10.1186/1472-6750-11-6
|
| 70 |
Thomas Tu, Nicholas A. Shackel, Geoffrey McCaughan. “Testing your methyl”: DNA methylation profiling of serum DNA of HCC patients. Hepatology International 2013; 7(3): 785 doi: 10.1007/s12072-013-9444-1
|
| 71 |
Hans Helmut Niller, Ferenc Banati, Eva Ay, Janos Minarovits. Patho-Epigenetics of Disease. 2012; : 179 doi: 10.1007/978-1-4614-3345-3_8
|
| 72 |
So Hyun Shin, Baek-hui Kim, Ja-June Jang, Kyung Suk Suh, Gyeong Hoon Kang. Identification of Novel Methylation Markers in Hepatocellular Carcinoma using a Methylation Array. Journal of Korean Medical Science 2010; 25(8): 1152 doi: 10.3346/jkms.2010.25.8.1152
|
| 73 |
Yi Tian, Weibing Yang, Jianxun Song, Yuzhang Wu, Bing Ni. Hepatitis B Virus X Protein-Induced Aberrant Epigenetic Modifications Contributing to Human Hepatocellular Carcinoma Pathogenesis. Molecular and Cellular Biology 2013; 33(15): 2810 doi: 10.1128/MCB.00205-13
|
| 74 |
Xun Hou, Jian-Xin Peng, Xiao-Yi Hao, Jian-Peng Cai, Li-Jian Liang, Jing-Ming Zhai, Kun-Song Zhang, Jia-Ming Lai, Xiao-Yu Yin. DNA Methylation Profiling Identifies EYA4 Gene as a Prognostic Molecular Marker in Hepatocellular Carcinoma. Annals of Surgical Oncology 2014; 21(12): 3891 doi: 10.1245/s10434-013-3401-z
|
| 75 |
Farmanur Rahman Khan, Saleh Sulaiman Alhewairini. Current Trends in Cancer Management. 2019; doi: 10.5772/intechopen.81517
|
| 76 |
Yuting Zhang, Huiting Huang, Libo Jin, Sue Lin. Anticarcinogenic Effects of Isothiocyanates on Hepatocellular Carcinoma. International Journal of Molecular Sciences 2022; 23(22): 13834 doi: 10.3390/ijms232213834
|
| 77 |
Jia-Horng Kao, Pei-Jer Chen, Ding-Shinn Chen. . Advances in Cancer Research 2010; 108: 21 doi: 10.1016/B978-0-12-380888-2.00002-9
|
| 78 |
Manjula Kiran, Yogesh K. Chawla, Jyotdeep Kaur. Methylation profiling of tumor suppressor genes and oncogenes in hepatitis virus-related hepatocellular carcinoma in northern India. Cancer Genetics and Cytogenetics 2009; 195(2): 112 doi: 10.1016/j.cancergencyto.2009.06.021
|
| 79 |
Utkarsh Raj, Pritish Kumar Varadwaj. Translational Bioinformatics and Its Application. Translational Medicine Research 2017; : 249 doi: 10.1007/978-94-024-1045-7_11
|
| 80 |
Liping Tang, Shasha Zhu, Weiyan Peng, Xuedong Yin, Cui Tan, Yaying Yang. Epigenetic identification of mitogen-activated protein kinase 10 as a functional tumor suppressor and clinical significance for hepatocellular carcinoma. PeerJ 2021; 9: e10810 doi: 10.7717/peerj.10810
|
| 81 |
A F Fernandez, M Esteller. Viral epigenomes in human tumorigenesis. Oncogene 2010; 29(10): 1405 doi: 10.1038/onc.2009.517
|
| 82 |
Xiu-Yan Huang, Zi-Li Huang, Yong-Hua Xu, Qi Zheng, Zi Chen, Wei Song, Jian Zhou, Zhao-You Tang, Xin-Yu Huang. Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-100338/miR-141-3p pathway in hepatitis B-related hepatocellular carcinoma. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-05432-8
|
| 83 |
Igor P. Pogribny, Levan Muskhelishvili, Volodymyr P. Tryndyak, Frederick A. Beland. The role of epigenetic events in genotoxic hepatocarcinogenesis induced by 2-acetylaminofluorene. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2011; 722(2): 106 doi: 10.1016/j.mrgentox.2010.02.011
|
| 84 |
Masumeh Sanaei, Fraidoon Kavoosi, Ali Ghasemi. Investigation of the effect of 5-Aza-2′-deoxycytidine on p15INK4, p16INK4, p18INK4, and p19INK4 genes expression, cell growth inhibition, and apoptosis induction in hepatocellular carcinoma PLC/PRF/5 cell line. Advanced Biomedical Research 2020; 9(1): 33 doi: 10.4103/abr.abr_68_20
|
| 85 |
Ivana Milosevic, Nevena Todorovic, Ana Filipovic, Jelena Simic, Marko Markovic, Olja Stevanovic, Jovan Malinic, Natasa Katanic, Nikola Mitrovic, Natasa Nikolic. HCV and HCC Tango—Deciphering the Intricate Dance of Disease: A Review Article. International Journal of Molecular Sciences 2023; 24(22): 16048 doi: 10.3390/ijms242216048
|
| 86 |
Grace Chappell, Kristy Kutanzi, Takeki Uehara, Volodymyr Tryndyak, Hue‐Hua Hong, Mark Hoenerhoff, Frederick A. Beland, Ivan Rusyn, Igor P. Pogribny. Genetic and epigenetic changes in fibrosis‐associated hepatocarcinogenesis in mice. International Journal of Cancer 2014; 134(12): 2778 doi: 10.1002/ijc.28610
|
| 87 |
Hans Helmut Niller, Janos Minarovits. Epigenetics in Human Disease. 2024; : 779 doi: 10.1016/B978-0-443-21863-7.00006-8
|
| 88 |
Andreas Teufel, Jens U. Marquardt, Frank Staib, Peter R. Galle. Snapshot liver transcriptome in hepatocellular carcinoma. Journal of Hepatology 2012; 56(4): 990 doi: 10.1016/j.jhep.2011.08.024
|
| 89 |
Ming-Chin Yu, Chao-Wei Lee, Chia-Hung Lin, Chun-Hsing Wu, Yun-Shien Lee, Chia-Lung Tsai, Chi-Neu Tsai. Differential hypermethylation of the VTRNA2-1 promoter in hepatocellular carcinoma as a prognostic factor: Tumor marker prognostic study. International Journal of Surgery 2020; 79: 282 doi: 10.1016/j.ijsu.2020.05.016
|
| 90 |
Binghua Li, Tiancheng Xu, Chaohui Liu, Gang Meng, Yuchen Sun, Liyuan Qian, Shaohe Wang, Jiwu Wei, Decai Yu, Yitao Ding. Liver-enriched Genes are Associated with the Prognosis of Patients with Hepatocellular Carcinoma. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-29237-5
|
| 91 |
Hans Helmut Niller, Janos Minarovits. Epigenetics in Human Disease. 2012; : 415 doi: 10.1016/B978-0-12-388415-2.00021-4
|
| 92 |
Philippe Couvert, Alain Carrié, Jacques Pariès, Jenny Vaysse, Audrey Miroglio, Antoine Kerjean, Pierre Nahon, Jamel Chelly, Jean-Claude Trinchet, Michel Beaugrand, Nathalie Ganne-Carrié. Liver <italic>insulin-like growth factor 2</italic> methylation in hepatitis C virus cirrhosis and further occurrence of hepatocellular carcinoma. World Journal of Gastroenterology 2008; 14(35): 5419-5427 doi: 10.3748/wjg.14.5419
|
| 93 |
Andreas C W Jenke, Kai O Hensel, Andreas Klein, Lisa Willuhn, Susanna Prax, Patrick P Weil, Theodor Winkler, Timo Deba, Valerie Orth, Armin Baiker, Stefan Wirth, Jan Postberg. Restitution of gene expression and histone acetylation signatures altered by hepatitis B virus through antiviral microRNA-like molecules in nontransformed murine hepatocytes. Clinical Epigenetics 2014; 6(1) doi: 10.1186/1868-7083-6-26
|
| 94 |
Seok Cho, Jae Hyek Lee, Sung Bum Cho, Kyeng Won Yoon, Seon Young Park, Wan Sik Lee, Chang Hwan Park, Young Eun Joo, Hyun Soo Kim, Sung Kyu Choi, Jong Sun Rew. Epigenetic methylation and expression of caspase 8 and survivin in hepatocellular carcinoma. Pathology International 2010; 60(3): 203 doi: 10.1111/j.1440-1827.2009.02507.x
|
| 95 |
Deeksha Rawat, Aarti Bains, Prince Chawla, Ravinder Kaushik, Rahul Yadav, Anil Kumar, Kandi Sridhar, Minaxi Sharma. Hazardous impacts of glyphosate on human and environment health: Occurrence and detection in food. Chemosphere 2023; 329: 138676 doi: 10.1016/j.chemosphere.2023.138676
|
| 96 |
Hoang van Tong, C. Thomas Bock, Thirumalaisamy P. Velavan. Genetic insights on host and hepatitis B virus in liver diseases. Mutation Research/Reviews in Mutation Research 2014; 762: 65 doi: 10.1016/j.mrrev.2014.06.001
|
| 97 |
Mitsuro Kanda, Hiroyuki Sugimoto, Yasuhiro Kodera. Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(37): 10584-10597 doi: 10.3748/wjg.v21.i37.10584
|
| 98 |
Feng‐Kai Sun, Qi Sun, Yu‐Chen Fan, Shuai Gao, Jing Zhao, Feng Li, Yi‐Bin Jia, Chuan Liu, Li‐Yuan Wang, Xin‐You Li, Xiang‐Fen Ji, Kai Wang. Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy. Journal of Gastroenterology and Hepatology 2016; 31(2): 484 doi: 10.1111/jgh.13154
|
| 99 |
Helmut Denk, Peter M. Abuja, Kurt Zatloukal. Mallory-Denk bodies and hepatocellular senescence: a causal relationship?. Virchows Archiv 2024; doi: 10.1007/s00428-024-03748-1
|
| 100 |
Franz Varga, Heidrun Karlic, Roman Thaler, Klaus Klaushofer. Functional aspects of cytidine-guanosine dinucleotides and their locations in genes. BioMolecular Concepts 2011; 2(5): 391 doi: 10.1515/BMC.2011.036
|
| 101 |
Fengguang Zhai, Jie Wang, Xia Luo, Meng Ye, Xiaofeng Jin. Roles of NOLC1 in cancers and viral infection. Journal of Cancer Research and Clinical Oncology 2023; 149(12): 10593 doi: 10.1007/s00432-023-04934-5
|
| 102 |
Fernando Salvador Moreno, Renato Heidor, Igor P. Pogribny. Nutritional Epigenetics and the Prevention of Hepatocellular Carcinoma with Bioactive Food Constituents. Nutrition and Cancer 2016; 68(5): 719 doi: 10.1080/01635581.2016.1180410
|
| 103 |
Binghua Dai, Li Geng, Yong Yu, Chengjun Sui, Feng Xie, Weifeng Shen, Tao Zheng, Jiamei Yang. Methylation patterns of estrogen receptor α promoter correlate with estrogen receptor α expression and clinicopathological factors in hepatocellular carcinoma. Experimental Biology and Medicine 2014; 239(7): 883 doi: 10.1177/1535370214536651
|
| 104 |
Yuting He, Qingmiao Shi, Yize Zhang, Xin Yuan, Zujiang Yu. <p>Transcriptome-Wide 5-Methylcytosine Functional Profiling of Long Non-Coding RNA in Hepatocellular Carcinoma</p>. Cancer Management and Research 2020; : 6877 doi: 10.2147/CMAR.S262450
|
| 105 |
Adélaïde Lerebours, Grant D. Stentiford, Brett P. Lyons, John P. Bignell, Stéphane A. P. Derocles, Jeanette M. Rotchell. Genetic Alterations and Cancer Formation in a European Flatfish at Sites of Different Contaminant Burdens. Environmental Science & Technology 2014; 48(17): 10448 doi: 10.1021/es502591p
|
| 106 |
Oliver Zolk, Martin F Fromm. Drug transporter regulation in tumors by DNA methylation. Genome Medicine 2012; 4(1): 10 doi: 10.1186/gm309
|
| 107 |
Galina Khemlina, Sadakatsu Ikeda, Razelle Kurzrock. The biology of Hepatocellular carcinoma: implications for genomic and immune therapies. Molecular Cancer 2017; 16(1) doi: 10.1186/s12943-017-0712-x
|
| 108 |
XUEFEI DUAN, JINQIAN ZHANG, SHUNAI LIU, MENGRAN ZHANG, QI WANG, JUN CHENG. Methylation of nucleolar and coiled-body phosphoprotein 1 is associated with the mechanism of tumorigenesis in hepatocellular carcinoma. Oncology Reports 2013; 30(5): 2220 doi: 10.3892/or.2013.2676
|
| 109 |
Ning-Hui Zhao, Yu Qian, Chen-Si Wu, Jing-Wen Wang, Yu Fang, Xiao-Peng Fan, Shuai Gao, Yu-Chen Fan, Kai Wang. Diagnostic value of NKG2D promoter methylation in hepatitis B virus-associated hepatocellular carcinoma. Biomarkers in Medicine 2019; 13(13): 1093 doi: 10.2217/bmm-2019-0102
|
| 110 |
Michel Neidhart. DNA Methylation and Complex Human Disease. 2016; : 81 doi: 10.1016/B978-0-12-420194-1.00006-3
|
| 111 |
Britta Laube, Sandra Michaelsen, Veronika Meischner, Andrea Hartwig, Bernd Epe, Michael Schwarz. Classification or non-classification of substances with positive tumor findings in animal studies: Guidance by the German MAK commission. Regulatory Toxicology and Pharmacology 2019; 108: 104444 doi: 10.1016/j.yrtph.2019.104444
|
| 112 |
Oscar C. Araújo, Agatha S. Rosa, Arlete Fernandes, Christian Niel, Cristiane A. Villela-Nogueira, Vera Pannain, Natalia M. Araujo, Isabelle A Chemin. RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients. PLOS ONE 2016; 11(4): e0153796 doi: 10.1371/journal.pone.0153796
|
| 113 |
Eivind Farmen, Maria Therese Hultman, Marc Anglès d’Auriac, Knut Erik Tollefsen. Development of a Screening System for the Detection of Chemically Induced DNA Methylation Alterations in a Zebrafish Liver Cell Line. Journal of Toxicology and Environmental Health, Part A 2014; 77(9-11): 587 doi: 10.1080/15287394.2014.887423
|
| 114 |
Jin-lin Peng, Ji-zhou Wu, Guo-jian Li, Jian-lin Wu, Yu-mei Xi, Xiao-qing Li, Lei Wang. Association of RASSF1A hypermethylation with risk of HBV/HCV-induced hepatocellular carcinoma: A meta-analysis. Pathology - Research and Practice 2020; 216(10): 153099 doi: 10.1016/j.prp.2020.153099
|
| 115 |
Diren Beyoğlu, Kristopher W. Krausz, Juliette Martin, Olivier Maurhofer, Juliane Dorow, Uta Ceglarek, Frank J. Gonzalez, Jean-François Dufour, Jeffrey R. Idle. Disruption of tumor suppressor gene Hint1 leads to remodeling of the lipid metabolic phenotype of mouse liver. Journal of Lipid Research 2014; 55(11): 2309 doi: 10.1194/jlr.M050682
|
| 116 |
Maria Ripoli, Raffaela Barbano, Teresa Balsamo, Claudia Piccoli, Virgilio Brunetti, Michelina Coco, Gianluigi Mazzoccoli, Manlio Vinciguerra, Valerio Pazienza. Hypermethylated levels of E-cadherin promoter in Huh-7 cells expressing the HCV core protein. Virus Research 2011; 160(1-2): 74 doi: 10.1016/j.virusres.2011.05.014
|
| 117 |
Carolina Simão Flausino, Filipe Ivan Daniel, Filipe Modolo. DNA methylation in oral squamous cell carcinoma: from its role in carcinogenesis to potential inhibitor drugs. Critical Reviews in Oncology/Hematology 2021; 164: 103399 doi: 10.1016/j.critrevonc.2021.103399
|
| 118 |
J. K. Jung, S.-H. Park, K. L. Jang. Hepatitis B virus X protein overcomes the growth-inhibitory potential of retinoic acid by downregulating retinoic acid receptor- 2 expression via DNA methylation. Journal of General Virology 2010; 91(2): 493 doi: 10.1099/vir.0.015149-0
|
| 119 |
Way-Champ Mah, Caroline GL Lee. DNA methylation: potential biomarker in Hepatocellular Carcinoma. Biomarker Research 2014; 2(1) doi: 10.1186/2050-7771-2-5
|
| 120 |
Rosina Maria Critelli, Elisabetta Cariani, Erica Villa. Cancer Genomics. 2013; : 163 doi: 10.1007/978-94-007-5842-1_6
|
| 121 |
Renumathy Dhanasekaran, Salome Bandoh, Lewis R. Roberts. Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances. F1000Research 2016; 5: 879 doi: 10.12688/f1000research.6946.1
|
| 122 |
Leda Mirbahai, Timothy D Williams, Huiqing Zhan, Zhiyuan Gong, J Kevin Chipman. Comprehensive profiling of zebrafish hepatic proximal promoter CpG island methylation and its modification during chemical carcinogenesis. BMC Genomics 2011; 12(1) doi: 10.1186/1471-2164-12-3
|
| 123 |
Hoang Van Tong, Pham Van Dung, Nguyen Thi Mong Diep, Nguyen Linh Toan. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach. 2022; doi: 10.5772/intechopen.98483
|
| 124 |
Kai O. Hensel, Julio C. Rendon, Maria‐Cristina Navas, Marianne G. Rots, Jan Postberg. Virus–host interplay in hepatitis B virus infection and epigenetic treatment strategies. The FEBS Journal 2017; 284(21): 3550 doi: 10.1111/febs.14094
|
| 125 |
Zdenko Herceg, Anupam Paliwal. Epigenetic mechanisms in hepatocellular carcinoma: How environmental factors influence the epigenome. Mutation Research/Reviews in Mutation Research 2011; 727(3): 55 doi: 10.1016/j.mrrev.2011.04.001
|
| 126 |
Hans Helmut Niller, Janos Minarovits. Epigenetics in Human Disease. 2018; : 643 doi: 10.1016/B978-0-12-812215-0.00021-2
|
| 127 |
Fatma El-shaarawy, Mai M. Abo ElAzm, Rasha H. Mohamed, Mohamed I. Radwan, Dina M. Abo-Elmatty, Eman T. Mehanna. Relation of the methylation state of RUNX3 and p16 gene promoters with hepatocellular carcinoma in Egyptian patients. Egyptian Journal of Medical Human Genetics 2022; 23(1) doi: 10.1186/s43042-022-00256-2
|
| 128 |
Keiko Takagi, Kyoko Fujiwara, Tadatoshi Takayama, Takao Mamiya, Masayoshi Soma, Hiroki Nagase. DNA hypermethylation of zygote arrest 1 (ZAR1) in hepatitis C virus positive related hepatocellular carcinoma. SpringerPlus 2013; 2(1) doi: 10.1186/2193-1801-2-150
|
| 129 |
Oranous Bashti Shiraz, Hamid Galehdari, Majid Yavarian, Bita Geramizadeh. Possible Down Regulation of the p16 Gene Promoter in Individuals with Hepatocellular Carcinoma. Hepatitis Monthly 2011; 11(9): 719 doi: 10.5812/kowsar.1735143X.588
|
| 130 |
Omar Ramos-Lopez, Jose I. Riezu-Boj, Fermin I. Milagro, J. Alfredo Martinez. Association of Methylation Signatures at Hepatocellular Carcinoma Pathway Genes with Adiposity and Insulin Resistance Phenotypes. Nutrition and Cancer 2019; 71(5): 840 doi: 10.1080/01635581.2018.1531136
|
| 131 |
Nithar Ranjan Madhu, Bhanumati Sarkar, Shubhadeep Roychoudhury, Biplab Kumar Behera. Handbook of Animal Models and its Uses in Cancer Research. 2022; : 1 doi: 10.1007/978-981-19-1282-5_61-1
|